Article Details

Dyadic International's (DYAI) CEO Mark Emalfarb on Q4 2021 Results - Earnings Call Transcript

Retrieved on: 2022-03-30 02:03:36

Tags for this article:

Click the tags to see associated articles and topics

Dyadic International's (DYAI) CEO Mark Emalfarb on Q4 2021 Results - Earnings Call Transcript. View article details on hiswai:

Excerpt

The synthetic biology market is categorized into the following segments, medical applications, industrial applications, food and agriculture, and ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up